Cosentyx (secukinumab) is a medication used to treat several conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a type of drug called a monoclonal antibody, which works by targeting and blocking a specific protein in the body that contributes to inflammation [1].

Regarding your vaccination plan, it is important to note that Cosentyx may affect your immune system's response to vaccines [2]. Specifically, live vaccines may not be recommended while taking Cosentyx, as the medication can potentially reduce the effectiveness of the vaccine and increase the risk of adverse reactions [2].

Before starting Cosentyx, you should discuss your vaccination history and future plans with your healthcare provider [2]. They may recommend that you receive any necessary live vaccines before beginning the medication or postpone the start of Cosentyx until after you have received the vaccines [2].

Inactivated or non-live vaccines are generally considered safe to receive while taking Cosentyx [2]. However, it is still essential to consult your healthcare provider, as individual circumstances may vary.

In summary, Cosentyx can affect your current vaccination plan by potentially impacting the effectiveness of live vaccines and increasing the risk of adverse reactions. It is crucial to discuss your vaccination history and future plans with your healthcare provider before starting Cosentyx [1][2].

Sources:

1. Cosentyx (secukinumab) [Internet]. Drugs.com. [cited 2023 Mar 1]. Available from: <https://www.drugs.com/cosentyx.html>.
2. Secukinumab (Cosentyx) [Internet]. DrugPatentWatch.com. [cited 2023 Mar 1]. Available from: <https://www.drugpatentwatch.com/drugs/secukinumab>.